Jean-Frederic Colombel

97PUBLICATIONS
315CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiologyInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (97)

|Sep 23, 2026
Persistence of mucosal CAR-T cells and inflammatory remodeling in enterocolitis associated with BCMA CAR-T cell therapy.

|Sep 18, 2026
The exposome and inflammatory bowel disease: a framework for primary and primordial prevention.

|Jul 21, 2026
Deciphering the prodrome of inflammatory bowel disease up to 10 years before disease onset by massively parallel serology.

|Jul 01, 2026
Engineering immune cell therapies for inflammatory bowel disease: from stem cells to CAR T cells.

|Apr 15, 2026
Impact of Immunogenicity on Clinical Outcomes in Patients With Moderate-to-Severe Inflammatory Bowel Disease Receiving Subcutaneous Infliximab: A Post Hoc Analysis of the LIBERTY Trials.

|Apr 13, 2026
Crohn's disease is an obstructive lymphangitis.

Herbert J Van Kruiningen, Jean-Frederic Colombel, Pietro Tonelli

Pageof 17

Frequent Collaborators

20 joint publications

Ryan Ungaro

17 joint publications

Manasi Agrawal

11 joint publications

Silvio Danese

10 joint publications

Joana Torres